Our Expanded Mission

In 2010, this website began when I realized that the practice of concentrating one’s carbohydrate intake into one meal daily — a practice first proposed by the Heller’s in their popular “Carbohydrate Addicts Diet” – might not only represent a practical strategy for lifelong weight control, but also, by keeping insulin levels relatively low for about 20 consecutive hours in each 24 hour span, provide some of the same health protection and longevity benefits achieved with calorie restriction and alternate-day fasting in animal studies.

In large part by practicing this “Carbohydrate Concentration” strategy, and by complementing it with exercise training, I am now 30 pounds lighter than I used to be, and I reversed my metabolic syndrome.

Biomedical scientist Mark McCarty worked with me to develop a website that set forth a scientific rationale for both the weight control benefits of Carb Concentration, and the likely beneficial impact of this strategy on healthful longevity. Although we initially may have seemed an odd pair of collaborators – I have long appreciated the “Atkinist” low-carb strategy, whereas Mark has long espoused a “Pritikinist” plant-based approach — we grasped the fact that Carb Concentration is an ecumenical strategy compatible with a wide range of dietary choices.

Throughout his career, Mark has been publishing speculative scientific reviews – primarily in the journal Medical Hypotheses. He now has over 240 publications in the Pubmed-cited biomedical literature. He researches and writes very quickly. At my request, he began writing on cancer, dementia, and Parkinson’s, and we began posting these reviews on the Catalytic Longevity website. In effect, he was “mining Medline” – surveying the peer-reviewed biomedical literature in an effort to draw practical conclusions regarding strategies that could promote health, and to offer insightful suggestions for future research.

As his contributions to the website continued to pile up, we changed the focus of the website, maintaining it as a resource for information on Carbohydrate Concentration, while putting greater emphasis on Mark’s wide-ranging and credible insights. After working with Mark for two years, I came to realize that, by virtue of his intellectual skill, background, energy, and interests, he was an international asset of great value in the world’s struggle for security against aging and disease, as well as a kind-hearted and selfless person. I have contacted some of his friends and associates for comments about him, which are posted here.

Mark is now turning out well-referenced papers at a rapid rate.  To make it easier for visitors to the website to find posted essays most pertinent to their interests, we have added a search engine that looks for key words in the titles and synopses of the posted essays.  For each paper, a “popular” synopsis has been written that summarizes the contents of the paper in language that should be intelligible to non-specialists readers.  Although most of the essays are written for biomedical scientists, some have been written especially for this website in a way that should make them accessible to the general public; the titles of these essays are set in red type.

Thanks to the liberal re-publication policy of Medical Hypotheses, we are also posting some of Mark’s earlier publications in this journal which are of continuing interest and are still reasonably consistent with the evolving research literature.  Also posted are pdfs of two monographs by Mark recently published in book form by Lambert Academic Publishers: Full-Spectrum Antioxidant Therapy, and Low-Fat, Low-Salt, Whole-Food Vegan.  It will be less expensive for you to print out your own copies.

Organizations or persons which want to retain Mark as a consultant to explain his work, and, especially, to help get his ideas promoted to the world at large can contact me at jstone@catalyticdiplomacy.org.

Our home page now links to a discussion of macrophage activating factor (GcMAF), a promising immunotherapy for cancer, and nagalase, a novel serum marker for cancer; both Mark and I think these have intriguing potential in cancer therapy, and we would like to acquaint cancer patients and their doctors with pertinent resources that are currently available.

Jeremy J. Stone

President, Federation of American Scientists (1970-2000); President, Catalytic Diplomacy (1999-present); President, Catalytic Longevity (2009-present): http://en.wikipedia.org/wiki/Jeremy_Stone.